| MolName | (5Z)-5-[[2-(3-hydroxypropylamino)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-3-(oxolan-2-ylmethyl)-2-sulfanylidene-1,3-thiazolidin-4-one |
| MolecularFormula | C20H22N4O4S2 |
| Smiles | OCCCNC(N=C1N2C=CC=C1)=C(/C=C(/C(N1CC3OCCC3)=O)\SC1=S)C2=O |
| InChI | InChI=1S/C20H22N4O4S2/c25-9-4-7-21-17-14(18(26)23-8-2-1-6-16(23)22-17)11-15-19(27)24(20(29)30-15)12-13-5-3-10-28-13/h1-2,6,8,11,13,21,25H,3-5,7,9-10,12H2/t13-/m1/s1 |
| InChIK | OBJDIMNXAGQZBT-CYBMUJFWSA-N |
| TotalMolweight | 446.551 |
| Molweight | 446.551 |
| MonoisotopicMass | 446.108246 |
| CLogP | -0.5014 |
| CLogS | -4.2 |
| H Acceptors | 8 |
| H Donors | 2 |
| TotalSurfaceArea | 326.03 |
| Relative PSA | 0.3826 |
| PolarSurfaceArea | 151.86 |
| Druglikeness | 2.6141 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.5 |
| Fragments | 1 |
| Non HAtoms | 30 |
| NonCHAtoms | 10 |
| Electronegative Atoms | 10 |
| StereoCenters | 1 |
| Rotatable Bond | 7 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Sp3Atoms | 12 |
| Amides | 2 |
| BasicNitrogens | 1 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (5Z)-5-[[2-(3-hydroxypropylamino)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-3-(oxolan-2-ylmethyl)-2-sulfanylidene-1,3-thiazolidin-4-one | 2 - (5Z)-5-[[2-(3-hydroxypropylamino)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-3-(oxolan-2-ylmethyl)-2-sulfanylidene-1,3-thiazolidin-4-one